Hudson Therapeutics And Shaperon Pursue Global Licensing Partnerships
07 Oct 2024 //
BUSINESSWIRE
Hudson And Shaperon Seek Global Licensing At Q4 Conferences
06 Oct 2024 //
BUSINESSWIRE
Hudson Therapeutics Enters Alopecia Areata Market
26 Sep 2024 //
BUSINESSWIRE
Korean firms Shaperon and Dong-A ST sign MoU for nanobody-based NDD
12 Jun 2024 //
BIOSPECTRUM ASIA
Shaperon And Dong-A ST Sign MOU For Nanobody-Based New Drug Development
10 Jun 2024 //
BUSINESSWIRE
Shaperon & Hudson to Participate in the 2024 Bio International Convention
30 May 2024 //
BUSINESSWIRE
Shaperon At Shanghai Healthcare Investment Conference
01 May 2024 //
BUSINESSWIRE
Shaperon Enrolls Its First Patient in Phase 2 U.S. Clinical Trial for `Nugel`
18 Mar 2024 //
BUSINESSWIRE